EXPLORING NEW PATHWAYS: PROCESS DEVELOPMENT FOR CEFETAMET SODIUM SYNTHESI
Ritesh Kumar Jat , Institute of Pharmacy, Shri Jagdishprasad Jhabarmal Tibrewala University, Jhunjhunu Rajasthan, IndiaAbstract
Cefetamet Sodium, a third-generation cephalosporin antibiotic, has gained significant attention due to its efficacy against a broad spectrum of bacterial infections. However, existing synthesis methods often present challenges such as low yields, complex procedures, and environmental concerns. This study presents a comprehensive approach to process development aimed at optimizing the synthesis of Cefetamet Sodium. We explored novel pathways, employing innovative synthetic routes and green chemistry principles to enhance yield and reduce waste. Key parameters including reaction conditions, catalyst selection, and purification techniques were systematically evaluated to establish an efficient and reproducible process. The results demonstrated significant improvements in overall yield and purity of the final product. Additionally, the developed process was assessed for scalability, feasibility, and economic viability. This research contributes valuable insights into the synthesis of Cefetamet Sodium, paving the way for more sustainable production practices in the pharmaceutical industry.
Keywords
Cefetamet Sodium, Antibiotic synthesis, Process development
References
Todd W. M.; Cefpodoxime proxetil: a comprehensive review Int. J. Antimicrobial Agents, 4, 1994, 37-62.
Bayer T, Zhou W, Holzhauer K, Schiigerl K.: Investigations of cephalosporin C production in an airlift tower loop reactor. Appl Microbiol Biotechnol, 1989; 30:26-33.
Heim J, Shen YQ, Wolfe S, Demain AL.: Regulation of isopenicillin N synthetase by carbon source during the fermentation of cephalosporium acremonium. Appl Microbiol Biotechnol 1984; 19:232-6.
Dollery, C. (1999) Therapeutic drugs. Churchill. 3rd ed, Livingstone, Edinburgh.
Cephalosporins and Penicillin, Chemistry and Biology. Edited by E. H. Flynn, Academic Press, New York and London, 84, 1972.
Jiang Jia-feng (Lunan Pharmaceutical Share Limited Corporation,Linyi 276006); Synthesis of Cefetamet pivoxil hydrochloride[J]; Qilu Pharmaceutical Affairs;2008-08
Muthadi F.J.; Hassan M. A.; Florey, K.; (Ed.) Analytical Profiles of Drug Substances, Academy Press, New York, vol. 11, 1982, 159.
United States XXII Pharmacopeia, the United States Pharmacopeia Convention Inc., 12601 Twin brook Parkway, Rockville, MD 20852, 1990, 249-250.
Indian Pharmacopeia, Ministry of health and family welfare, Govt. of India, New Delhi; controller of publication, 2nd ed, 1996, A-740
Indian Pharmacopeia, Ministry of health and family welfare, Govt. of India, New Delhi; controller of publication, 4th ed, 1996, A-54
Xian Yang1,Long Enwu1,Yuan Haoyu2(1.Sichuan Provincial People's Hospital,Sichuan Academy of Medical Science,Chengdu,Sichuan,China 610072;2.416 Hospital of Nuclear Industry Ministry,Chengdu,Sichuan,China 610051); Determination of Cefetamet Pivoxil Hydrochloride Capsules by RP-HPLC[J];China Pharmaceuticals;2010-07
Fang Yulan, Harbin Pharmaceutical Grop Co, Ltd General Pharm Factory 150086; Determine the Content of Cefetamet Pivoxit Hydrochloride in the Tablet of Cefetamet Pivoxit Hydrochloride With HPLC[J];Heilongjiang Medical Journal;2002-0 1
Article Statistics
Copyright License
Copyright (c) 2024 Ritesh Kumar Jat
This work is licensed under a Creative Commons Attribution 4.0 International License.